InVivo Therapeutics (NSDQ:NVIV) said today it added a new patient to the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The new patient was added at Charlotte, N.C.’s Carolinas Medical Center. Surgery was […]
InVivo Therapeutics
InVivo Therapeutics adds patient to Inspire spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today it added a new patient to the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The new patient was added at Portland, Ore.’s Oregon Health & Science University. […]
Analogic CEO Green steps away | Personnel Moves Nov 4, 2016
Analogic (NSDQ:ALOG) said late last month its prez and CEO James Green has stepped away from his position to pursue other opportunities. Company director and former Enovate Medical exec chair and CEO Dr. Fred Parks has been named to take over Green’s position. “Jim Green led Analogic during a period of meaningful development and growth, and […]
InVivo adds 26th clinical site for spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today it added a new site to the ongoing Inspire clinical study of its neuro-spinal scaffold designed to treat patients with complete thoracic AIS A spinal cord injuries.. The new site is located at the Allegheny General Hospital in Pittsburgh, Penn., and brings the total number of centers in the trial up to […]
InVivo adds Beth Israel, Canadian site to neuro-spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today that Boston’s Beth Israel Deaconess Medical Center and Alberta, Canada’s Foothills Medical Center to the Inspire study of its neuro-spinal scaffold. The additions bring the total number of sites up to 25 for the trial of the neuro-spinal scaffold, which is designed to treat patients with complete thoracic AIS A spinal […]
Northwestern Memorial joins InVivo Therapeutics neuro-spinal scaffold trial
InVivo Therapeutics (NSDQ:NVIV) said today that Chicago’s Northwestern Memorial Hospital is the 23rd site to join the clinical trial of its neuro-spinal scaffold. “Chicago, as with other major metropolitan areas, sees a disproportionally high number of acute, traumatic spinal cord injuries and unfortunately, with complete spinal cord injuries, trauma teams have limited tools at their disposal to […]
Another InVivo Therapeutics spinal scaffold implant patient improves
InVivo Therapeutics (NSDQ:NVIV) said today that the 9th spinal cord injury patient, implanted with its neuro-spinal scaffold last month, is already showing signs of improvement. InVivo’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. The 9th patient in a clinical trial improved from a complete to incomplete […]
Seno Medical grabs ex-CeloNova CFO Davis | Personnel Moves August 12, 2016
Seno Medical grabs ex-CeloNova CFO Davis Seno Medical Instuments said this week it tapped former CeloNova BioSciences chief financial officer Eric Davis to take over the CFO role at Seno Medical. Prior to his years at CeloNova, Davis operated as CFO and operating officer at Genesis Networks Enterprises. Seno Medical said that Davis has more than […]
InVivo Therapeutics Q2 meets the street, shares stay steady
InVivo Therapeutics (NSDQ:NVIV) shares stayed steady after the company released 2nd quarter earnings that met the street on losses per share. The Cambridge, Mass.-based company reported losses of $5.2 million, or 16¢ per share, for the 3 months ended June 30, 2016. That amounts to a 50% reduction in losses for InVivo Therapeutics compared with same […]
InVivo Therapeutics adds another clinical site
InVivo Therapeutics (NSDQ:NVIV) said today that it added another site to the clinical trial of its neurospinal scaffold, taking the total number of participating sites to 22. That includes the 1st Canadian site, added last week after Health Canada OK’d the trial. The latest site to join the Inspire study is the Ben Taub Hospital at the […]
Health Canada OKs trial for InVivo Therapeutics spine scaffold
UPDATED July 14, 2016, with news of 1st Canadian trial site. Just a day after the FDA approved the expansion of the Inspire study of its neuro-spinal scaffold, InVivo Therapeutics (NSDQ:NVIV) said Health Canada granted investigational testing authorization for the study. Today the company said the Toronto Western Hospital’s Research Ethics Board approved its participation in the […]